» Articles » PMID: 33086487

Molecular Aspects of Thyroid Calcification

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2020 Oct 22
PMID 33086487
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

In thyroid cancer, calcification is mainly present in classical papillary thyroid carcinoma (PTC) and in medullary thyroid carcinoma (MTC), despite being described in benign lesions and in other subtypes of thyroid carcinomas. Thyroid calcifications are classified according to their diameter and location. At ultrasonography, microcalcifications appear as hyperechoic spots ≤ 1 mm in diameter and can be named as stromal calcification, bone formation, or psammoma bodies (PBs), whereas calcifications > 1 mm are macrocalcifications. The mechanism of their formation is still poorly understood. Microcalcifications are generally accepted as a reliable indicator of malignancy as they mostly represent PBs. In order to progress in terms of the understanding of the mechanisms behind calcification occurring in thyroid tumors in general, and in PTC in particular, we decided to use histopathology as the basis of the possible cellular and molecular mechanisms of calcification formation in thyroid cancer. We explored the involvement of molecules such as runt-related transcription factor-2 (Runx-2), osteonectin/secreted protein acidic and rich in cysteine (SPARC), alkaline phosphatase (ALP), bone sialoprotein (BSP), and osteopontin (OPN) in the formation of calcification. The present review offers a novel insight into the mechanisms underlying the development of calcification in thyroid cancer.

Citing Articles

Predicting central lymph node metastasis in papillary thyroid carcinoma combined with Hashimoto's thyroiditis: a preoperative study.

Lou P, Huang Y, Li H, Zhao F, Xu J, Wang K BMC Cancer. 2025; 25(1):425.

PMID: 40065226 PMC: 11892260. DOI: 10.1186/s12885-025-13805-w.


Psammoma bodies in thyroid: are they always indicative of malignancy? A multi-institutional study.

Rossi E, Agarwal S, Erkilic S, Hang J, Jalaly J, Khanafshar E Virchows Arch. 2024; 485(5):853-858.

PMID: 39349665 PMC: 11564275. DOI: 10.1007/s00428-024-03934-1.


Factors Affecting Cell Viability during the Enzymatic Dissociation of Human Endocrine Tumor Tissues.

Shcherbakova A, Utkina M, Valyaeva A, Pachuashvili N, Bondarenko E, Urusova L Biology (Basel). 2024; 13(9).

PMID: 39336093 PMC: 11429318. DOI: 10.3390/biology13090665.


A nomogram for risk stratification of central cervical lymph node metastasis in patients with papillary thyroid carcinoma.

Zou Y, Shi Y, Bi H, Tan J, Guo Q, Qin Y Quant Imaging Med Surg. 2024; 14(7):5084-5098.

PMID: 39022275 PMC: 11250316. DOI: 10.21037/qims-24-284.


Personalized Management of Malignant and Non-Malignant Ectopic Mediastinal Thyroid: A Proposed 10-Item Algorithm Approach.

Carsote M, Ciobica M, Sima O, Ciuche A, Popa-Velea O, Stanciu M Cancers (Basel). 2024; 16(10).

PMID: 38791947 PMC: 11120123. DOI: 10.3390/cancers16101868.


References
1.
Smith-Bindman R, Lebda P, Feldstein V, Sellami D, Goldstein R, Brasic N . Risk of thyroid cancer based on thyroid ultrasound imaging characteristics: results of a population-based study. JAMA Intern Med. 2013; 173(19):1788-96. PMC: 3936789. DOI: 10.1001/jamainternmed.2013.9245. View

2.
Sharma T, Radosevich J, Pachori G, Mandal C . A Molecular View of Pathological Microcalcification in Breast Cancer. J Mammary Gland Biol Neoplasia. 2016; 21(1-2):25-40. DOI: 10.1007/s10911-015-9349-9. View

3.
Kim H, Choi D, Yun S, Choi S, Kang J, Jung J . Proteomic analysis of microvesicles derived from human mesenchymal stem cells. J Proteome Res. 2011; 11(2):839-49. DOI: 10.1021/pr200682z. View

4.
Orimo H . The mechanism of mineralization and the role of alkaline phosphatase in health and disease. J Nippon Med Sch. 2010; 77(1):4-12. DOI: 10.1272/jnms.77.4. View

5.
Kaartinen M, Pirhonen A, Linnala-Kankkunen A, Maenpaa P . Cross-linking of osteopontin by tissue transglutaminase increases its collagen binding properties. J Biol Chem. 1999; 274(3):1729-35. DOI: 10.1074/jbc.274.3.1729. View